417. Should We Be Doing This? Evaluating Pleural Fluid Inoculation into Blood Culture Bottles

Abstract Background Sterile fluid inoculation into blood culture (BCx) bottles has primarily been shown to be beneficial with peritoneal fluid. However, we have observed widespread expansion of this practice for other sterile fluid specimens at our institution. We investigated whether there was a clinical benefit to inoculating pleural fluid specimens into BCx bottles. Methods This was a retrospective chart review of patients who had pleural fluid inoculated into BCx bottles from July 1, 2021 through June 30, 2023. Clinical, microbiologic, and pharmacy data were extracted from medical records of patients that had at least one organism isolated from these samples and had a routine (non-blood culture bottle inoculation) pleural fluid culture sent from the same procedure. The primary outcome was the proportion of clinically relevant organisms based on evaluation by the primary or a consultant team. Results A total of 334 pleural fluid specimens were inoculated into BCx bottles during the study period; positive cultures were found in 12.2% (41/334). Five patients were excluded as they did not have a concomitant routine pleural fluid culture, leaving a study cohort of 36 patients. In the study cohort (n=36), 61.1% (22/36) had the same organism(s) isolated from both BCx inoculated and routine pleural fluid cultures, while 38.9% (14/36) had additional organisms from the BCx bottle inoculated specimens that were not isolated on the routine pleural fluid culture. Of the 14 patients with additional organisms from BCx bottle inoculation (Table 1), 4 were deemed contaminants. Ten patients had clinically relevant organisms and 4 of these led to changes in antimicrobial management (change in agent or duration). Overall, 3% (10/334) of specimens with pleural fluid inoculated into BCx bottles had a clinically relevant organism that was not isolated in routine culture. 1.2% (4/334) of specimens led to a change in clinical management based on the additional organism(s) isolated. Conclusion In our single-institution study, we found widespread practice of inoculating pleural fluid into blood culture bottles. The practice may slightly increase microbiological yield over routine fluid cultures, but few patients had a change in clinical management at our institution. Disclosures All Authors: No reported disclosures

Authors

Institutions

Publication Details

Journal
Open Forum Infectious Diseases
Published
2025-01-29
DOI
https://doi.org/10.1093/ofid/ofae631.131
Primary Topic
Sepsis Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

417. Should We Be Doing This? Evaluating Pleural Fluid Inoculation into Blood Culture Bottles

Matthew S. Lee, J Hunter Fraker
Open Forum Infectious Diseases
Sepsis Diagnosis and Treatment
article

417. Should We Be Doing This? Evaluating Pleural Fluid Inoculation into Blood Culture Bottles

Matthew S. Lee, J Hunter Fraker
article en

Abstract

Abstract Background Sterile fluid inoculation into blood culture (BCx) bottles has primarily been shown to be beneficial with peritoneal fluid. However, we have observed widespread expansion of this practice for other sterile fluid specimens at our institution. We investigated whether there was a clinical benefit to inoculating pleural fluid specimens into BCx bottles. Methods This was a retrospective chart review of patients who had pleural fluid inoculated into BCx bottles from July 1, 2021 through June 30, 2023. Clinical, microbiologic, and pharmacy data were extracted from medical records of patients that had at least one organism isolated from these samples and had a routine (non-blood culture bottle inoculation) pleural fluid culture sent from the same procedure. The primary outcome was the proportion of clinically relevant organisms based on evaluation by the primary or a consultant team. Results A total of 334 pleural fluid specimens were inoculated into BCx bottles during the study period; positive cultures were found in 12.2% (41/334). Five patients were excluded as they did not have a concomitant routine pleural fluid culture, leaving a study cohort of 36 patients. In the study cohort (n=36), 61.1% (22/36) had the same organism(s) isolated from both BCx inoculated and routine pleural fluid cultures, while 38.9% (14/36) had additional organisms from the BCx bottle inoculated specimens that were not isolated on the routine pleural fluid culture. Of the 14 patients with additional organisms from BCx bottle inoculation (Table 1), 4 were deemed contaminants. Ten patients had clinically relevant organisms and 4 of these led to changes in antimicrobial management (change in agent or duration). Overall, 3% (10/334) of specimens with pleural fluid inoculated into BCx bottles had a clinically relevant organism that was not isolated in routine culture. 1.2% (4/334) of specimens led to a change in clinical management based on the additional organism(s) isolated. Conclusion In our single-institution study, we found widespread practice of inoculating pleural fluid into blood culture bottles. The practice may slightly increase microbiological yield over routine fluid cultures, but few patients had a change in clinical management at our institution. Disclosures All Authors: No reported disclosures

Open Forum Infectious DiseasesVol. 12(Supplement_1)
Beth Israel Deaconess Medical Center (US)
Openalex Percentile: Top 98%
Sepsis Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.